Movetis

Movetis

Movetis

Movetis is focused on the development of drugs for the treatment of diseases in the gastrointestinal area.
Founded
2006
Raised
$191.2M
Follow us
Alexa global traffic share
Acquired by
ViroPharma Inc.
03 Aug 2010
$565,000,000
Latest funding
$127,500,000
Private equity - 2009
$63,729,400
Venture capital (Series A) - 2007
Location
Headquarters

No recent coverage

Index constantly checks hot and trending companies for their latest activity. We haven't gotten to this company yet, but if you follow it you'll be the the first to know when Movetis makes some noise.